Longitudinal association between hippocampus atrophy and episodic-memory decline in non-demented APOE ε4 carriers Show others and affiliations
2020 (English) In: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, E-ISSN 2352-8729, Vol. 12, no 1, article id e12110Article in journal (Refereed) Published
Abstract [en]
Introduction: The apolipoprotein E (APOE) ε4 allele is the main genetic risk factor for Alzheimer's disease (AD), accelerated cognitive aging, and hippocampal atrophy, but its influence on the association between hippocampus atrophy and episodic-memory decline in non-demented individuals remains unclear.
Methods: We analyzed longitudinal (two to six observations) magnetic resonance imaging (MRI)–derived hippocampal volumes and episodic memory from 748 individuals (55 to 90 years at baseline, 50% female) from the European Lifebrain consortium.
Results: The change-change association for hippocampal volume and memory was significant only in ε4 carriers (N = 173, r = 0.21, P = .007; non-carriers: N = 467, r = 0.073,P = .117). The linear relationship was significantly steeper for the carriers [t(629) =2.4, P = .013]. A similar trend toward a stronger change-change relation for carriers was seen in a subsample with more than two assessments.
Discussion: These findings provide evidence for a difference in hippocampus-memory association between ε4 carriers and non-carriers, thus highlighting how genetic factors modulate the translation of the AD-related pathophysiological cascade into cognitive deficits.
Place, publisher, year, edition, pages John Wiley & Sons, 2020. Vol. 12, no 1, article id e12110
Keywords [en]
apolipoprotein (APOE) ε4, hippocampus, longitudinal, memory, MRI
National Category
Neurosciences
Identifiers URN: urn:nbn:se:umu:diva-175957 DOI: 10.1002/dad2.12110 ISI: 000707203600106 Scopus ID: 2-s2.0-85100596109 OAI: oai:DiVA.org:umu-175957 DiVA, id: diva2:1476501
Funder EU, Horizon 2020, 732592 2020-10-142020-10-142023-09-05 Bibliographically approved